Terms: = Gastric cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825
18355 results:
1. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract] [Full Text] [Related]
2. Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy.
Yan J; Bhadane R; Ran M; Ma X; Li Y; Zheng D; Salo-Ahen OMH; Zhang H
Nat Commun; 2024 May; 15(1):3684. PubMed ID: 38693181
[TBL] [Abstract] [Full Text] [Related]
3. Helicobacter pylori with trx1 high expression promotes gastric diseases via upregulating the IL23A/NF-κB/IL8 pathway.
Guan X; Ning J; Fu W; Wang Y; Zhang J; Ding S
Helicobacter; 2024; 29(2):e13072. PubMed ID: 38686467
[TBL] [Abstract] [Full Text] [Related]
4. Aldehyde Dehydrogenese-1 High cancer Stem-like Cells/cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
Shirosaki T; Kawai N; Ebihara Y; Murai A; Kubo T; Morita R; Murata K; Kanaseki T; Tsukahara T; Shichinohe T; Hirohashi Y; Hirano S; Torigoe T
Anticancer Res; 2024 May; 44(5):1877-1883. PubMed ID: 38677758
[TBL] [Abstract] [Full Text] [Related]
5. Treatment of Cachexia in gastric cancer: Exploring the Use of Anti-Inflammatory Natural Products and Their Derivatives.
Loyala JV; Down B; Wong E; Tan B
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674936
[TBL] [Abstract] [Full Text] [Related]
6. The Important Role of GPX1 and NF-κB Signaling Pathway in Human gastric cancer: Implications for Cell Proliferation and Invasion.
Jang BI; Jung JY; Koh SA; Lee KH
Cancer Genomics Proteomics; 2024 Apr; 21(3):305-315. PubMed ID: 38670589
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Park MH; Seo JH; Park JH; Seong MK; Park KU; Kim MK; Chang M; Koh SJ; Lee MH; Lim ST; Yoo YB; Oh SY; Kim SH; Ahn KY; Park TH; Ju H; Baek EH; Kim S; Kim N; Lee E; Kim TH
Expert Opin Biol Ther; 2024 Apr; 24(4):305-312. PubMed ID: 38664937
[TBL] [Abstract] [Full Text] [Related]
8. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
Perri G; Vilas Boas VG; Nogueira MRS; Mello Júnior EJF; Coelho AL; Posadas EM; Hogaboam C; Cavassani KA; Campanelli AP
Cancer Immunol Immunother; 2024 Apr; 73(6):110. PubMed ID: 38662248
[TBL] [Abstract] [Full Text] [Related]
9. UBE2L3 expression in human gastric cancer and its clinical significance.
Zhang X; Wei Y; Wu F; Li M; Han C; Huo C; Li Z; Tang F; He W; Zhao Y; Li Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):210. PubMed ID: 38656363
[TBL] [Abstract] [Full Text] [Related]
10. Critical roles of long noncoding RNA H19 in cancer.
Darmadi D; Chugaeva UY; Saleh RO; Hjazi A; Saleem HM; Ghildiyal P; Alwaily ER; Alawadi A; Alnajar MJ; Ihsan A
Cell Biochem Funct; 2024 Apr; 42(3):e4018. PubMed ID: 38644608
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of YS-1 as a cell line of gastric inflammatory cancer-associated fibroblasts.
Numakura S; Kato M; Uozaki H
Mol Biol Rep; 2024 Apr; 51(1):542. PubMed ID: 38642200
[TBL] [Abstract] [Full Text] [Related]
12. Mitochondrial dysfunction induced by HIF-1α under hypoxia contributes to the development of gastric mucosal lesions.
Xiao Y; Liu X; Xie K; Luo J; Zhang Y; Huang X; Luo J; Tan S
Clin Transl Med; 2024 Apr; 14(4):e1653. PubMed ID: 38616702
[TBL] [Abstract] [Full Text] [Related]
13. Probing the expression and adhesion of glycans involved in Helicobacter pylori infection.
Sijmons D; Collett S; Soliman C; Guy AJ; Scott AM; Durrant LG; Elbourne A; Walduck AK; Ramsland PA
Sci Rep; 2024 Apr; 14(1):8587. PubMed ID: 38615147
[TBL] [Abstract] [Full Text] [Related]
14. Exploring the Therapeutic Effects of
Choi NR; Choi WG; Zhu A; Park J; Kim YT; Hong J; Kim BJ
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612999
[No Abstract] [Full Text] [Related]
15.
Kalisperati P; Spanou E; Pateras IS; Evangelou K; Thymara I; Korkolopoulou P; Kotsinas A; Vlachoyiannopoulos PG; Tzioufas AG; Kanellopoulos C; Gorgoulis VG; Sougioultzis S
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612698
[No Abstract] [Full Text] [Related]
16. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
[TBL] [Abstract] [Full Text] [Related]
17. Establishment of a Novel cancer-Specific Anti-HER2 Monoclonal Antibody H
Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):35-43. PubMed ID: 38563783
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of HLA-DR and HLA-DQ expression in gastric cancer tissues.
Jafari N; Khajenabi F; Masumi N; Abediankenari S; Ranjbaran H
J Cancer Res Ther; 2024 Jan; 20(1):204-210. PubMed ID: 38554322
[TBL] [Abstract] [Full Text] [Related]
19. DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy.
Ma Z; Zhou Z; Duan W; Yao G; Sheng S; Zong S; Zhang X; Li C; Liu Y; Ou F; Dahar MR; Huang Y; Yu L
Cancer Immunol Immunother; 2024 Mar; 73(5):82. PubMed ID: 38554200
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy of immune checkpoint inhibitors differs in various status of carcinoma: a study based on 29 cohorts with 3255 participants.
Wu C; Ke Y; Wan L; Xie X
Cancer Immunol Immunother; 2024 Mar; 73(5):79. PubMed ID: 38554165
[TBL] [Abstract] [Full Text] [Related]
[Next]
